Page last updated: 2024-11-08

pentylenetetrazole and Organophosphorus Poisoning

pentylenetetrazole has been researched along with Organophosphorus Poisoning in 2 studies

Pentylenetetrazole: A pharmaceutical agent that displays activity as a central nervous system and respiratory stimulant. It is considered a non-competitive GAMMA-AMINOBUTYRIC ACID antagonist. Pentylenetetrazole has been used experimentally to study seizure phenomenon and to identify pharmaceuticals that may control seizure susceptibility.
pentetrazol : An organic heterobicyclic compound that is 1H-tetrazole in which the hydrogens at positions 1 and 5 are replaced by a pentane-1,5-diyl group. A central and respiratory stimulant, it was formerly used for the treatment of cough and other respiratory tract disorders, cardiovascular disorders including hypotension, and pruritis.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Alipour, V1
Hoseinpour, F1
Vatanparast, J1
Green, DM1
Muir, AW1
Stratton, JA1
Inch, TD1

Other Studies

2 other studies available for pentylenetetrazole and Organophosphorus Poisoning

ArticleYear
Persistent alterations in seizure susceptibility, drug responsiveness and comorbidities associated with chemical kindling after neonatal exposure to an organophosphate.
    Neurotoxicology, 2019, Volume: 73

    Topics: Affect; Animals; Animals, Newborn; Anticonvulsants; Behavior, Animal; Brain; Chlorpyrifos; Cholinest

2019
Dual mechanism of the antidotal action of atropine-like drugs in poisoning by organophosphorus anticholinesterases.
    The Journal of pharmacy and pharmacology, 1977, Volume: 29, Issue:1

    Topics: Animals; Anticonvulsants; Antidotes; Atropine; Cholinesterase Inhibitors; Dose-Response Relationship

1977